cholesteryl succinate has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryson, KF; Fariss, MW; Hylton, EE; Lippman, HR; Stubin, CH; Zhao, XG | 1 |
| Fariss, MW; Lippman, HR; Mumaw, VR; Ray, SD | 1 |
2 other study(ies) available for cholesteryl succinate and Liver Dysfunction
| Article | Year |
|---|---|
Protection against carbon tetrachloride-induced hepatotoxicity by pretreating rats with the hemisuccinate esters of tocopherol and cholesterol.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cholesterol Esters; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Tocopherols; Vitamin E | 1993 |
Cholesteryl hemisuccinate treatment protects rodents from the toxic effects of acetaminophen, adriamycin, carbon tetrachloride, chloroform and galactosamine.
Topics: Acetaminophen; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chloroform; Cholesterol Esters; Doxorubicin; Galactosamine; Heart Diseases; Liver Diseases; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley | 1997 |